These can range from mild (like nausea) to rare-but-serious (like kidney issues or vision changes in people with advanced diabetes)
Nutrient-dense GLP-1 recipes that pack substantial nutrition into small volumes are especially valuable here, because they allow you to increase caloric and protein intake without needing a large appetite
placebo on the time to occurrence of a composite cardiovascular outcome (nonfatal myocardial infarction, nonfatal stroke, cardiovascular death, hospitalization or urgent visit due to heart failure) and a composite renal outcome (end-stage kidney disease, 40% sustained decline in eGFR, cardiovascular death or renal death) in 10,000 individuals with atherosclerotic cardiovascular disease and/or CKD
Funding This study was supported and funded by Boehringer Ingelheim
Ask your prescribing provider to switch your prescription to a semaglutide-pyridoxine formulation, which the compounding pharmacy will prepare